Cyclic RNA vaccine shows neutral activity against B.1.351 variant
A new preclinical study led by Wensheng Wei of Peking University in China has developed a circular RNA vaccine recommendation. Their findings showed that the cyclic RNA vaccine produces neutral ant…
.jpg)